NBS Pharmaceuticals

CURRENT PRODUCTS

NBS Pharmaceuticals, the drug subsidiary of Northland Bioscience, offers a wide range of medications in numerous dosage and delivery methods. It is our commitment to offer the highest quality pharmaceuticals to achieve maximal efficacy and patient safety. Our product quality and corporate excellence stems from our belief that each person, anywhere in the world, should have the opportunity to live the healthiest life possible.

ANTIMICROBIALS

Despite considerable advances in modern medicine, infectious disease remains the leading cause of mortality and morbidity in the developing world. With the highest quality production and delivery standards, NBS Pharmaceuticals is committed to the effective treatment of infectious disease not only from a medical perspective but from the perspective of community service--contributing to improvements in population health. 

METABOLIC

According to the World Health Organization (WHO), the worldwide prevalence of diabetes approaches 10%.  Third world and developing countries continue to see the greatest yearly rise in prevalence. Metformin and Glyburide remain the preferred first line oral therapies for Type 2 diabetes.  At NBS Pharmaceuticals, our production cycle is fully capable of meeting the increasing global need of metabolic drugs.  Bioavailability profile, stability metrics, and quality standards meet or exceed all regulatory standards for these time proven medications. 

ANALGESICS

The worldwide opioid crisis has forced healthcare professionals to seek alternative methods in achieving pain control for their patients.  In addition to offering the widely used OTC analgesics (Ibuprofen, Diclofenac, and Acetaminophen), NBS Pharmaceuticals’ product list also includes topical analgesics which offer a safer means of pain control than their oral counterparts.

ONCOLOGY

By 2022, the worldwide expenditure in battling oncologic disease will exceed 138B USD; a greater than 50% increase relative to the 2017 expenditure of 80B USD.  Cancer medications account for 15% of the total oncologic expenditure.  And as newer, costlier medications are continuously in development, it is important to remind governing agencies and healthcare delivery systems that high quality generic chemotherapy drugs will remain an essential component of effective therapy.

CARDIOVASCULAR

Cardiovascular drugs maintain a continuous demand worldwide considering the prevalence of heart disease in nearly all cultures irrespective of geography.  NBS Pharmaceuticals provides the highest quality profile and efficacy metrics in this class of drugs.  Our most common drugs in this category include:  antiarrhythmics, antihypertensive, and cholesterol/lipid lowering medications.

VACCINES

Unforeseen events such as famine, natural disasters, and war can stress a region's population health infrastructure beyond capacity.  Vaccine supply can reach a critical level; endangering the lives of millions in a very short span of time.  NBS Pharmaceuticals via its extensive network of government agencies and private industry can help in such times of need; providing the necessary medications to local officials and relief organizations in hopes of curtailing a public health crisis. 

NEUROSCIENCES

An aging world-wide population is more susceptible to degenerative neurological disease, particularly movement disorders and dementia. NBS Pharmaceuticals offers high quality neuro-modulating medications to provide patients with sustained relief from debilitating symptoms.